Nasdaq Stockholm AB: ChromoGenics AB receives observation status

Today, May 23, 2024, Färna Invest AB disclosed a public takeover offer to the
shareholders in ChromoGenics AB. 

The rules of Nasdaq First North Growth Market state that an issuer may be given
observation status if the issuer is subject to a public takeover offer. 

With reference to the above, Nasdaq Stockholm AB decides that the shares in
ChromoGenics AB (CHRO, ISIN code SE0020847481, order book ID 135174) shall be
given observation status. 

For further information about this exchange notice please contact Enforcement &
Investigations, telephone [phone]. 


Nasdaq Stockholm AB